* MILLEGEN *
1999 - Midi-Pyrénées
Labège
(near Toulouse)
www.millegen.com Contract, Manufacturing
(also, Development, Drugs)
Key words: Directed Molecular Evolution (DME), MutaGen, Mutascreen, Gene cloning, High throughput screening, Antibodies, Peptides
Mission: to develop and and genetically engineer new human therapeutic antibodies based on proprietary Directed Molecular Evolution platform, for third parties and for own pipeline (also, to offer custom services including high-throughput DNA sequencing, bioinformatics, gene cloning and vector development services, peptides synthesis and antibodies engineering and production)
Clients: Pharmaceutical industry, Research labs, Biotechs
contact@millegen.com
Age: 12 year(s)
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS |
|---|
| Personal venture |
Managing Dir.-CEO: Kharrat (Abdel Hakim) [co-founder, born 1961, Ph.D. biology, Ms. Management, ex-EMBL Heidelberg]
Sc.Dir.-CSO: Bouayadi (Khalil) [co-founder, Ph.D. molecular pharmacology]
I.T.Dir.-CIO: Crozet (Fabien) [Ph.D. molecular neurobiology]
Fin.Dir.-CFO:
BusDev: Deflisque (Anne) [Ms. biochemistry, ex-GE Healthcare]
Financers (Hist.): privately owned (registered capital 2006 = 0.07 M€) | Turnover (M€) : 1.5 (2009), 1.5 (2008), 1.2 (2006)
Total funding (M€) : 0.6
Last funding (M€) : 0.6
Focus : Multiple
Position : Subcontractor
Company confirm : neutral |
History | DATE | MILESTONE | TYPE | TIME |
|---|
| 2010 .08 | Research : publication in Methods Mol Biology of random mutagenesis method (human error-prone DNA polymerases) | R&D | [10 years] |
| 2010 .03 | Patent : granted on molecular evolution technology (MutaGen) by US office | LEGAL | [10 years] |
| 2008 .05 | Partnering research agreement with Accuro Biologics on reciprocal expertise | R&D | [8 years] |
| 2007 .03 | Partnering research agreement with LFB to develop new generation of therapeutic monoclonal antibodies | R&D | [7 years] |
| 2005 .09 | Partnering research agreement with Pierre Fabre, bio-informatics | R&D | [5 years] |
| 2001 .12 | Launch of MutalGen platform, a mutagenesis platform | MKTG | [2 years] |
| 1999 .10 | Company founded by 2 researchers, Hakim Kharrat and Khalil Bouayadi | ORGF | [0 year] | Actualisation / Updating: 11-Oct-2010 |
|
